BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5377767)

  • 41. Inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza A virus.
    Mizuta T; Fujiwara M; Abe T; Miyano-Kurosaki N; Yokota T; Shigeta S; Takaku H
    Biochem Biophys Res Commun; 2000 Dec; 279(1):158-61. PubMed ID: 11112432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral effects of rhIFN-alpha 1 against seven influenza viruses.
    Li F; Wang QJ; Zhu BL; Wang M
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):709-14. PubMed ID: 10678103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative study of influenza virus neuraminidases, using automated techniques.
    Kendal AP; Madeley CR
    Biochim Biophys Acta; 1969 Jul; 185(1):163-77. PubMed ID: 5816010
    [No Abstract]   [Full Text] [Related]  

  • 44. Antival activity of cyclooctylamine hydrochloride in influenza virus-infected ferrets.
    Pinto CA; Haff RF
    Antimicrob Agents Chemother (Bethesda); 1968; 8():201-6. PubMed ID: 5735361
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiviral compounds. II. Screening of synthetic organic compounds against influenza virus.
    Nishimura T; Taguchi F; Saito M; Hasegawa K; Nagaki D
    Kitasato Arch Exp Med; 1972 Jun; 45(2):105-23. PubMed ID: 4665956
    [No Abstract]   [Full Text] [Related]  

  • 46. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
    Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
    Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Influence of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid on Myxovirus-neuraminidases and the replication of influenza- and Newcastle disease virus].
    Meindl P; Bodo G; Lindner J; Palese P
    Z Naturforsch B; 1971 Aug; 26(8):792-7. PubMed ID: 4399278
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative studies on influenza B virus. II. The effect of host cells on biological properties and polypeptide composition.
    Simanovskaya VK; Korchanova NL; Sominina AA; Kuznetsova EV
    Acta Virol; 1983 Sep; 27(5):385-92. PubMed ID: 6139941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Respiratory virus inhibitors in the colostrum of Chinese donors.
    Shortridge KF; Wong R
    J Trop Med Hyg; 1974 May; 77(5):94-102. PubMed ID: 4366198
    [No Abstract]   [Full Text] [Related]  

  • 50. [A comparative study of the effects of actinomycetes of the genera Actinomyces and Micromonospora on the processes of phage, vaccinia and influenza virus multiplication].
    Singal EM; Fadeeva NP; Goncharskaia TIa; Solov'eva NK
    Antibiotiki; 1974 Apr; 19(4):339-41. PubMed ID: 4463872
    [No Abstract]   [Full Text] [Related]  

  • 51. [Recent acquisitions in the biology of influenza viruses].
    Moisa I
    Stud Cercet Inframicrobiol; 1971; 22(2):143-70. PubMed ID: 4935751
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors.
    Hastings JC; Selnick H; Wolanski B; Tomassini JE
    Antimicrob Agents Chemother; 1996 May; 40(5):1304-7. PubMed ID: 8723491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The antiviral activity of caprochlorone.
    Stanfield FJ; Haff RF; Stewart RC
    Proc Soc Exp Biol Med; 1967 May; 125(1):297-303. PubMed ID: 6027546
    [No Abstract]   [Full Text] [Related]  

  • 54. [Antiviral properties of the pigments from bacteria of the genus Pseudomonas].
    Mil'chenko KP; Kiprianova EA; Boĭko OI
    Mikrobiol Zh; 1976; 38(1):24-8. PubMed ID: 823395
    [No Abstract]   [Full Text] [Related]  

  • 55. Inhibition of a cold variant of influenza virus by selected chemicals.
    Cochran KW; Maassab HF
    Arch Environ Health; 1970 Sep; 21(3):312-5. PubMed ID: 5504432
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of phospholipase C on influenza viruses: limited release of "soluble" V-antigens and of neuraminidase.
    Neurath AR; Rubin BA
    Life Sci; 1967 Mar; 6(6):575-80. PubMed ID: 4291878
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antiviral effects of some biguanide derivatives].
    Denys A; Bialek J; Machlański T
    Med Dosw Mikrobiol; 1976; 28(1):77-82. PubMed ID: 176542
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibitory activity of benzoyl hydrazides and hydrazine on the growth of influenza virus in chick embryo lung tissue culture.
    Kundin WD; Robbins ML; Smith PK
    Experientia; 1964 Aug; 20(8):438-9. PubMed ID: 5892811
    [No Abstract]   [Full Text] [Related]  

  • 59. [Participation of the proteolysis system in promoting the virulence of the influenza virus and development of the infectious process; the antiviral effect of protease inhibitors].
    Lozitskiĭ VP; Fedchuk AS; Puzis LE; Buĭko VP; Girlia IuI
    Vopr Virusol; 1987; 32(4):413-9. PubMed ID: 3318131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification of bovine serum beta-inhibitor by chromatographic methods and its reaction with A1 influenza virus.
    Krizanová O; Sokol F
    Acta Virol; 1966 Jan; 10(1):35-42. PubMed ID: 4380769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.